Background: Pleural malignancy either primary or due to metastatic involvement can be presented by different macroscopic appearances in thoracoscopic examination of pleural cavity.
Introduction
Malignant pleural effusion (MPE) is one of the most common problems faced by clinicians in their everyday practice [1] . MPE usually presents in the disseminated and advanced stage of malignancy [2] . In one postmortem series, malignant effusions were found in 15% of patients who died with malignancies. Although there have been no epidemiologic studies, malignant pleural effusion is also one of the leading causes of exudative effusion; studies have demonstrated that 42-77% of exudative effusions are secondary to malignancy [1] . Nearly all neoplasms have been reported to involve the pleura. In most studies, however, lung carcinoma has been the most common neoplasm, accounting for approximately one third of all malignant effusions. Breast carcinoma is the second most common. Lymphomas, including both Hodgkin's disease and non-Hodgkin's lymphoma, are also an important cause of malignant pleural effusions. In 5-10% of malignant effusions, no primary tumor is identified [3] . The incidence of mesothelioma varies according to the geographic location. Postmortem studies suggest that most pleural metastases arise from tumor emboli to the visceral pleural surface, with secondary seeding to the parietal pleura. Other possible mechanisms include direct tumor invasion (in lung cancers, chest wall neoplasm and breast carcinoma), haematogenous spread to parietal pleura and lymphatic involvement. Interference with the integrity of the lymphatic system anywhere between the parietal pleura and mediastinal lymph nodes can result in pleural fluid formation [4] . Thoracoscopy is highly sensitive for detecting pleural neoplasia with negative pleural fluid cytology [5] . The possibility of visualizing the pleural cavity and obtaining directed biopsy specimens accounts for diagnosis of more than 90% of pleural neoplasia [6] [7] [8] . However, its precise indication in the workup of patients with pleural effusion remains controversial [9] . So; the aim of this study is to identify the relationship between thoracoscopic view of different malignant pleural lesions and pathological types of malignancy in malignant pleural effusion.
Subjects and methods

Patients
A retrospective study reviewed medical thoracoscopic reports of 69 patients with pleural effusion underwent medical thoracoscopy and confirmed to be malignant in the chest department of Mansoura University hospital between January 2013 and April 2014.
Methods
Prethoracoscopy assessment
For each patient, the following were reviewed: (1) detailed medical history, (2) investigations done to reach the final diagnosis including; chest radiographs and chest-CTs, pleural aspiration with cytology and closed pleural biopsy.
Thoracoscopy procedure
Prior to the thoracoscopy procedure, pleural effusion was drained and ipsilateral pneumothorax was induced, both in the endoscopy suite. Thoracoscopy was usually done under local anesthesia with spontaneous breathing and mild sedation (midazolam, fentanyl) by an experienced pulmonologist in the operating room. Patients were placed in lateral decubitus position, with the involved side upward. After skin sterilization, a small skin incision was done with blunt dissection to enter the pleural space between the third and sixth intercostal space, along the midaxillary line. The ribs were not spread. A rigid thoracoscope (Karl Storz, Germany) was inserted, and the pleural cavity was visualized. The parietal, visceral and diaphragmatic pleurae were successively inspected and any pathological lesions were described and identified as well as the mediastinal vessels and lymph nodes were inspected also. Biopsies were performed under direct visual control in all suspect areas, systematically in several parts of the parietal pleura, and sometimes in the visceral pleura, with diathermy forceps. All thoracoscopic pleural biopsies were stained by hematoxylin and eosin and examined by an expert pathologist to diagnose the histopathological type of malignancy. An intercostal tube was inserted before wound closure to evacuate air and fluid. Chest radiographs were routinely obtained with a portable unit, immediately after the procedure and daily thereafter until chest tube removal. On malignant diagnosis cases underwent pleurodesis routinely. Once the lung had expanded and drain output had decreased to less than 50 ml per 24 h, chest tube was removed.
Postthoracoscopy assessment
The recorded major and minor complications were considered. Major complications were retrospectively defined as events requiring active medical management during the hospital stay. Minor complications were events requiring medical supervision only. The duration of drainage was measured from the day medical thoracoscopy was performed to the day on which the chest tube was removed.
Statistical analysis
Data were analyzed using SPSS (Statistical Package for Social Sciences) version 21. Qualitative data were presented as number and percentage. Quantitative data were presented for normality by Kolmogorov-Smirnov test. Normally distributed data were presented as mean and standard deviation. Comparison between final diagnosis was done using Chi-square test. P value <0.05 was considered significant.
Results
The mean age of studied population was 53.59 years with standard deviation 11.9 with age range from 20 to 78 years. Fortyone were males (59.45%) and twenty-eight of them were females (40.6%). As revealed in Table 1 , according to final diagnosis; cases with malignant pleural effusion were categorized into metastatic adenocarcinoma (46 cases 66.7%), malignant lymphoma (9 cases 13%) malignant mesothelioma and metastatic squamous cell carcinoma (4 cases 5.8% for each) small cell carcinoma (3 cases 4.3%), sarcoma (2 cases 2.9%) and spindle cell tumor (one case 1.4%).
As revealed in Table 2 malignant pleural effusion showed higher percentage in thoracoscopic nodules (75.45%) followed by masses (50.7%), plaques (20.3%) and last of all adhesions (14.5%). Metastatic adenocarcinoma proved to be in higher percentage in thoracoscopic nodules (82.6%) followed by mass (45.65%) while adhesions and plaques were present in 10.86% for each. Malignant lymphoma presented higher percentage in thoracoscopic nodules also (77.78%) followed by masses (66.67%) then thoracoscopic plaques and adhesions 44.45% for each. Malignant mesothelioma demonstrated higher percentage in thoracoscopic mass (100%) followed by thoracoscopic nodules (50%). Thoracoscopic mass and plaques were present in all cases with sarcoma while adhesions represented in half of the cases. 2/3 of small cell carcinoma presented plaques however only 1/3 of cases presented nodules. Spindle cell tumor represented only in one case that revealed just thoracoscopic mass. All cases of metastatic squamous cell carcinoma had nodules unlike masses and plaques that were present in 25% of cases. To be noted more than one finding may be present in the patient. Significant statistical differences were present as regards all thoracoscopic findings apart from thoracoscopic adhesions.
In this study as shown in Table 3 , the presence of more than one thoracoscopic finding may refer to certain diagnosis or aid in confirming the malignancy consequently presence of two thoracoscopic findings accounted for 77.8% of cases with malignant lymphoma while malignant mesothelioma presented equal percentage for one or two findings (50% for each). Metastatic adenocarcinoma showed higher percentage of one finding (54.3%) followed by two findings (41.3%) lastly three findings (4.3%), sarcoma and metastatic squamous cell carcinoma demonstrated equal percentage for two types, the former showed two and three findings and the latter showed one and two thoracoscopic findings. Spindle cell tumor and small cell carcinoma proved that one finding was present in each thoracoscopic examination.
In this study, medical thoracoscopy revealed that all cases with pleural plaques were detected on the parietal pleura however the rest of cases with pleural nodules, masses were present on in both visceral and parietal layers and cases with isolated lesions on either layer could not be delineated. In addition we could not demarcate specific lesions for pleural partitions as costal, diaphragmatic or mediastinal parts due to the degree of extension. Adhesions also were involving both pleural layers.
Complications reported in this study were few and of low risk. Five patients (7.25%) had thoracoscopic-related complications during this study. Two of them had empyema (2.89%); one had a residual pneumothorax (1.45%), one had subcutaneous emphysema (1.45%) and one had tumor implantation at the site of medical thoracoscopy tract (1.45%). These complications were properly managed. No bleeding or mortality was reported in our study and mortality rate was 0%.
Discussion
Over the time, medical thoracoscopy (MT) is still confirming that the dilemma of pleural effusion could not be actually worked out without its help. In this study sixty-nine patients underwent MT and showed malignant etiology of pleura effusion. Various types of macroscopic features (mass, nodules, plaques and adhesions) in pleural layers; visceral and parietal; can be visualized including costal, mediastinal and diaphragmatic partitions. For these, MT can be valuable in magnification of panoramic view of the hemithorax with high resolution for details as well as allows adequate biopsy specimens access for histologic, and possibly immunocytologic examination [10] , and also gives the option for therapeutic procedures to be performed like decortication, pleurectomy, mechanical pleurodesis, talc insufflation and last but not least, visual directed placement of chest drains [11] . As revealed in Table 2 malignant pleural effusion showed higher percentage in thoracoscopic nodules (75.45%) followed by masses (50.7%), plaques (20.3%) and lastly adhesions in 14.5% of cases. This may be due to higher number of cases of metastatic adenocarcinoma and malignant lymphoma ( Table 1 ) that are mainly presented by nodules (82.6% and 77.78%, respectively) ( Table 2 ). This was in agreement with study done by Jiang et al. (2013) [12] who found that; the endoscopic findings of malignant pleural effusion mostly showed nodules of varying sizes. The nodules could be grape-like, cauliflower-like, fused into masses, or diffused small nodules and the main pathological diagnosis of malignant pleural effusion was pleural metastases (37.8% of cases). Metastatic adenocarcinoma proved to be in higher percentage in thoracoscopic nodules (82.6%) this can be explained by implantation theory of pleural metastasis and hematogenous dissemination followed by mass (45.65%) while adhesions and plaques were present in 10.86% for each. Malignant lymphoma presented higher percentage in thoracoscopic nodules also (77.78%) followed by masses (66.67%) then thoracoscopic plaques and adhesions that showed 44.45% for each owing to dense lymphatic pleural enrichment and local form of spread. The classic view of malignant pleural mesothelioma is a thickening in the pleural space with encasement of the lung by rind like visceral pleura. The tumor can form additional small nodules over the diaphragmatic surfaces or other less involved areas. Hyalinized pleural plaques over the parietal pleura and diaphragmatic surface can become invaded by mesothelioma. Rare cases of malignant mesothelioma are characterized by a single mass lesion without the diffuse thickening or satellite nodules [13] .
In this study malignant mesothelioma demonstrated higher percentage in thoracoscopic mass (100%) followed by thoracoscopic nodules (50%); this due to small number of cases as well as most of them were of mixed subtype.
Visually, according to England et al. (1991) , sarcomatous pleural tumors appeared round or ovoid in shape. They were encapsulated and attached to the visceral, parietal, or, in 1 case, the intraparenchymal pleura by a pedicle. Two-thirds of the tumors were attached to visceral pleura, often by a pedicle. The rest arose from the parietal pleura of the chest wall, diaphragm, or mediastinum. Neoplasms in these atypical sites, together with fissural lesions and tumors ''inverted'' into peripheral lung, were more often malignant [14] . In our study thoracoscopic mass and plaques were present in all cases with sarcoma due to fleshy tumor type while adhesions represented in half of the cases.
Two thirds of small cell carcinoma presented plaques however only one third presented nodules. Spindle cell tumor was represented only in one case that revealed just thoracoscopic mass. All cases of metastatic squamous cell carcinoma had nodules, however, masses and plaques were present in 25% of cases. Significant statistical differences were present in all thoracoscopic findings apart from adhesions.
A study done by Rodriquez-Panadero et al. (1989) [15] and Light (2001) [16] , demonstrated that involvement of the parietal pleura is frequently patchy and that the parietal pleura is involved later in the course of malignancy than the visceral one.
In our study; medical thoracoscopy revealed that all the cases of the pleural plaques were of parietal origin while the rest of cases with nodules, masses were in both visceral and parietal pleurae referring to the extensive degree of pleural affection and advanced form of malignancy.
In this study presence of more than one thoracoscopic finding may refer to certain diagnosis or aid in confirming the malignancy. Two thoracoscopic findings account for 77.8% of cases with malignant lymphoma while malignant mesothelioma presented equal percentage for one and two findings (50% for each). Metastatic adenocarcinoma viewed higher proportion for one finding (54.3%) followed by two findings (41.3%) lastly three findings (4.3%). Sarcoma and metastatic squamous cell carcinoma demonstrated equal percentage for each, the former for two and three thoracoscopic findings and the later for one and two thoracoscopic findings. Spindle cell tumor and small cell carcinoma proved that one finding presented in their thoracoscopic examination. The presence of more than one finding can increase the feasibility of biopsy taking and hence diagnostic yields and accuracy especially in tumors needing larger tissue sampling as lymphoma and malignant mesothelioma as declared in study by Loddenkemper (1998) [17] who stated that medical thoracoscopy should be systematically performed, as it provides a better histological classification (larger biopsy specimens), and more precise staging, thus avoiding thoracotomy. In a series, malignancy was strongly suspected in the initial evaluation of patients in whom hidden neoplasm was later detected [18] , [19] ; and, alternatively, when malignancy was not initially suspected, it was detected in only 5% of the patients who were followed up [20] . However, what does ''high clinical suspicion of malignancy'' mean, and how can it be used in the workup of patients with undiagnosed pleural effusion? Patients with malignant pleural effusion present clinical differences compared with those with benign effusions [21, 22] . Medical thoracoscopy is a fairly safe procedure when performed by a well-trained physician. Few minor complications were reported in our study. Five patients (7.25%) had thoracoscopic-related complications during this study. Two patients had empyema; one patient had a residual pneumothorax, one patient had subcutaneous emphysema and one patient had a tumor implantation at the site of the tract of medical thoracoscopy. These complications were properly managed. No bleeding or mortality was reported in our study and mortality rate was 0%.
According to Shawgo (2000) [23] , the main risks of thoracoscopy are those associated with early complications after the procedure as pulmonary edema and excessive bleeding and or hemorrhage necessitating a thoracotomy to stop it. According to a retrospective study by Blanc et al. (2002) [24] of 168 cases, thoracoscopic complications detected were classified into major complications that included death, severe sepsis, pulmonary embolism, hypercapnic coma these were of equal incidence of percentage 0.6%, while empyema was detected in (3.6%) of cases. On the other hand minor complications included residual pneumothorax (8.3%), subcutaneous emphysema (5.3%), fever (3.6%) and opiates were prescribed in 1.2% to control post procedure chest pain. In another study Cho et al. (2002) [25] reported some cases of cardiac arrhythmia-bradycardia <60 bpm in 13.6%, hypotension-ABP <100 mmHg in 24.2% and hypoxemia-arterial SpO2 <90% in 16.7% during thoracoscopic procedure.
Conclusion
Medical thoracoscopy plays an important role in the diagnosis and management of malignant pleural effusions through direct access, visualization, handling, biopsy and intervention. Thoracoscopic appearance of malignant pleural lesions like masses, nodules, plaques and adhesions may predict the suspected pathological type of malignancy causing malignant pleural effusion.
